The cell competition-based high-throughput screening identifies small compounds that promote the elimination of RasV12-transformed cells from epithelia

Hajime Yamauchi, Takanori Matsumaru, Tomoko Morita, Susumu Ishikawa, Katsumi Maenaka, Ichigaku Takigawa, Kentaro Semba, Shunsuke Kon, Yasuyuki Fujita

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Recent studies have revealed that cell competition can occur between normal and transformed epithelial cells; normal epithelial cells recognize the presence of the neighboring transformed cells and actively eliminate them from epithelial tissues. Here, we have established a brand-new high-throughput screening platform that targets cell competition. By using this platform, we have identified Rebeccamycin as a hit compound that specifically promotes elimination of RasV12-transformed cells from the epithelium, though after longer treatment it shows substantial cytotoxic effect against normal epithelial cells. Among several Rebeccamycin-derivative compounds, we have found that VC1-8 has least cytotoxicity against normal cells but shows the comparable effect on the elimination of transformed cells. This cell competition-promoting activity of VC1-8 is observed both in vitro and ex vivo. These data demonstrate that the cell competition-based screening is a promising tool for the establishment of a novel type of cancer preventive medicine.

Original languageEnglish
Article number15336
JournalScientific Reports
Volume5
DOIs
Publication statusPublished - 2015 Oct 20
Externally publishedYes

Fingerprint

Epithelium
Epithelial Cells
Preventive Medicine
Neoplasms

ASJC Scopus subject areas

  • General

Cite this

The cell competition-based high-throughput screening identifies small compounds that promote the elimination of RasV12-transformed cells from epithelia. / Yamauchi, Hajime; Matsumaru, Takanori; Morita, Tomoko; Ishikawa, Susumu; Maenaka, Katsumi; Takigawa, Ichigaku; Semba, Kentaro; Kon, Shunsuke; Fujita, Yasuyuki.

In: Scientific Reports, Vol. 5, 15336, 20.10.2015.

Research output: Contribution to journalArticle

Yamauchi, Hajime ; Matsumaru, Takanori ; Morita, Tomoko ; Ishikawa, Susumu ; Maenaka, Katsumi ; Takigawa, Ichigaku ; Semba, Kentaro ; Kon, Shunsuke ; Fujita, Yasuyuki. / The cell competition-based high-throughput screening identifies small compounds that promote the elimination of RasV12-transformed cells from epithelia. In: Scientific Reports. 2015 ; Vol. 5.
@article{aa65ba6a10574ff7ae93b7e0036a2fb9,
title = "The cell competition-based high-throughput screening identifies small compounds that promote the elimination of RasV12-transformed cells from epithelia",
abstract = "Recent studies have revealed that cell competition can occur between normal and transformed epithelial cells; normal epithelial cells recognize the presence of the neighboring transformed cells and actively eliminate them from epithelial tissues. Here, we have established a brand-new high-throughput screening platform that targets cell competition. By using this platform, we have identified Rebeccamycin as a hit compound that specifically promotes elimination of RasV12-transformed cells from the epithelium, though after longer treatment it shows substantial cytotoxic effect against normal epithelial cells. Among several Rebeccamycin-derivative compounds, we have found that VC1-8 has least cytotoxicity against normal cells but shows the comparable effect on the elimination of transformed cells. This cell competition-promoting activity of VC1-8 is observed both in vitro and ex vivo. These data demonstrate that the cell competition-based screening is a promising tool for the establishment of a novel type of cancer preventive medicine.",
author = "Hajime Yamauchi and Takanori Matsumaru and Tomoko Morita and Susumu Ishikawa and Katsumi Maenaka and Ichigaku Takigawa and Kentaro Semba and Shunsuke Kon and Yasuyuki Fujita",
year = "2015",
month = "10",
day = "20",
doi = "10.1038/srep15336",
language = "English",
volume = "5",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - The cell competition-based high-throughput screening identifies small compounds that promote the elimination of RasV12-transformed cells from epithelia

AU - Yamauchi, Hajime

AU - Matsumaru, Takanori

AU - Morita, Tomoko

AU - Ishikawa, Susumu

AU - Maenaka, Katsumi

AU - Takigawa, Ichigaku

AU - Semba, Kentaro

AU - Kon, Shunsuke

AU - Fujita, Yasuyuki

PY - 2015/10/20

Y1 - 2015/10/20

N2 - Recent studies have revealed that cell competition can occur between normal and transformed epithelial cells; normal epithelial cells recognize the presence of the neighboring transformed cells and actively eliminate them from epithelial tissues. Here, we have established a brand-new high-throughput screening platform that targets cell competition. By using this platform, we have identified Rebeccamycin as a hit compound that specifically promotes elimination of RasV12-transformed cells from the epithelium, though after longer treatment it shows substantial cytotoxic effect against normal epithelial cells. Among several Rebeccamycin-derivative compounds, we have found that VC1-8 has least cytotoxicity against normal cells but shows the comparable effect on the elimination of transformed cells. This cell competition-promoting activity of VC1-8 is observed both in vitro and ex vivo. These data demonstrate that the cell competition-based screening is a promising tool for the establishment of a novel type of cancer preventive medicine.

AB - Recent studies have revealed that cell competition can occur between normal and transformed epithelial cells; normal epithelial cells recognize the presence of the neighboring transformed cells and actively eliminate them from epithelial tissues. Here, we have established a brand-new high-throughput screening platform that targets cell competition. By using this platform, we have identified Rebeccamycin as a hit compound that specifically promotes elimination of RasV12-transformed cells from the epithelium, though after longer treatment it shows substantial cytotoxic effect against normal epithelial cells. Among several Rebeccamycin-derivative compounds, we have found that VC1-8 has least cytotoxicity against normal cells but shows the comparable effect on the elimination of transformed cells. This cell competition-promoting activity of VC1-8 is observed both in vitro and ex vivo. These data demonstrate that the cell competition-based screening is a promising tool for the establishment of a novel type of cancer preventive medicine.

UR - http://www.scopus.com/inward/record.url?scp=84944789880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944789880&partnerID=8YFLogxK

U2 - 10.1038/srep15336

DO - 10.1038/srep15336

M3 - Article

VL - 5

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 15336

ER -